Weiss Multi Strategy Advisers LLC Bio Xcel Therapeutics, Inc. Transaction History

Weiss Multi Strategy Advisers LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$15.0 - $22.83 $449,595 - $684,283	-29,973 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$20.12 - $35.09 $2,273 - $3,965	-113 Reduced 0.38%	29,973 $609,000
Q3 2021 Nov 15, 2021	BUY	$23.84 - $32.03 $40,671 - $54,643	1,706 Added 6.01%	30,086 $913,000
Q2 2021 Aug 16, 2021	BUY	$29.06 - $38.83 $182,380 - $243,697	6,276 Added 28.39%	28,380 $825,000
Q1 2021 May 14, 2021	BUY	$39.04 - $64.6 $126,528 - $209,368	3,241 Added 17.18%	22,104 $954,000
Q4 2020 Feb 16, 2021	BUY	$42.46 - $56.58 $158,036 - $210,590	3,722 Added 24.58%	18,863 $871,000
Q3 2020 Nov 16, 2020	BUY	$37.44 - $64.63 $566,879 - $978,562	15,141 New	15,141 $657,000

3.11M

22.2K

40.2K

Ticker BTAI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,022,500
Market Cap $7.85M
Description
BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and prop...

Get notified when there are updates to the investment portfolio of Weiss Multi Strategy Advisers LLC, based on Form 13F filings with the SEC.

Stay updated on Weiss Multi Strategy Advisers LLC with notifications on news.